Search Results - "WASCHER, T. C."

Refine Results
  1. 1

    The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study by Leber, B, Tripolt, N J, Blattl, D, Eder, M, Wascher, T C, Pieber, T R, Stauber, R, Sourij, H, Oettl, K, Stadlbauer, V

    Published in European journal of clinical nutrition (01-10-2012)
    “…Background/objectives: Obesity and metabolic disorders are linked to inflammation via gut microbiota and/or gut permeability. Gut-derived endotoxin triggers…”
    Get full text
    Journal Article
  2. 2

    Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance by Wascher, T. C., Schmoelzer, I., Wiegratz, A., Stuehlinger, M., Mueller-Wieland, D., Kotzka, J., Enderle, M.

    Published in European journal of clinical investigation (01-09-2005)
    “…Objectives  To investigate whether selective reduction of postchallenge hyperglycaemia influences acute endothelial dysfunction, a very early manifestation of…”
    Get full text
    Journal Article
  3. 3

    Non-glycemic effects of insulin therapy: a comparison between insulin aspart and regular human insulin during two consecutive meals in patients with type 2 diabetes by Sourij, H, Schmoelzer, I, de Campo, A, Tripolt, N J, Stojakovic, T, Scharnagl, H, Kettler-Schmut, E, Forst, T, Wascher, T C

    Published in European journal of endocrinology (01-08-2011)
    “…ObjectiveTo control postprandial hyperglycemia in insulin-treated type 2 diabetic patients, prandial therapy with regular human insulin (HI) or fast acting…”
    Get full text
    Journal Article
  4. 4

    Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events by Stojakovic, T., De Campo, A., Scharnagl, H., Sourij, H., Schmölzer, I., Wascher, T. C., März, W.

    Published in European journal of clinical investigation (01-03-2010)
    “…Eur J Clin Invest 2010; 40 (3): 187–194 Background  Ezetimibe, a cholesterol‐absorption inhibitor, significantly lowers low‐density lipoprotein cholesterol…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Injection therapy of diabetes by Lechleitner, Monika, Roden, Michael, Weitgasser, Raimund, Ludvik, Bernhard, Fasching, Peter, Hoppichler, Friedrich, Kautzky-Willer, Alexandra, Schernthaner, Guntram, Prager, Rudolf, Kaser, Susanne, Wascher, T C

    Published in Wiener Klinische Wochenschrift (01-01-2023)
    “…The present article is a recommendation of the Austrian Diabetes Association for the practical use of injection therapy (GLP1-receptor agonists and insulin) in…”
    Get full text
    Journal Article
  7. 7

    The alpha-amino group of l-arginine mediates its antioxidant effect by Wallner, S., Hermetter, A., Mayer, B., Wascher, T. C.

    Published in European journal of clinical investigation (01-02-2001)
    “…Antioxidant effects may constitute part of the possible antiatherogenic effects of the amino acid l‐arginine. These antioxidant properties were further…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Low-fat, high-carbohydrate (low-glycaemic index) diet induces weight loss and preserves lean body mass in obese healthy subjects: results of a 24-week study by Bahadori, B., Yazdani-Biuki, B., Krippl, P., Brath, H., Uitz, E., Wascher, T. C.

    Published in Diabetes, obesity & metabolism (01-05-2005)
    “…Background:  The traditional treatment for obesity which is based on a reduced caloric diet has only been partially successful. Contributing factors are not…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Effects of low-dose l-arginine on insulin-mediated vasodilatation and insulin sensitivity by WASCHER, T. C., GRAIER, W. F., DITTRICH, P., HUSSAIN, M. A., BAHADORI, B., WALLNER, S., TOPLAK, H.

    Published in European journal of clinical investigation (01-08-1997)
    “…The present study was carried out to evaluate the effect of a low‐dose intravenous supplementation of l‐arginine on insulin‐mediated vasodilatation and insulin…”
    Get full text
    Journal Article
  12. 12

    Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells by POSCH, K, SIMECEK, S, WASCHER, T. C, JÜRGENS, G, BAUMGARTNER-PARZER, S, KOSTNER, G. M, GRAIER, W. F

    Published in Diabetes (New York, N.Y.) (01-06-1999)
    “…Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in…”
    Get full text
    Journal Article
  13. 13

    Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production by SCHAEFFER, G, WASCHER, T. C, KOSTNER, G. M, GRAIER, W. F

    Published in Diabetologia (01-02-1999)
    “…Increased aggregation of platelets might contribute to the development of vascular complication in diabetes mellitus. In this study release of superoxide…”
    Get full text
    Journal Article
  14. 14

    Multifactorial risk factor intervention in patients with Type2 diabetes improves arginine bioavailability ratios by Tripolt, N J, Meinitzer, A, Eder, M, Wascher, T C, Pieber, T R, Sourij, H

    Published in Diabetic medicine (01-10-2012)
    “…Aim Endothelial dysfunction is defined by reduced bioavailability of nitric oxide and has been shown to be associated with cardiovascular risk. The global…”
    Get full text
    Journal Article
  15. 15

    Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios by Tripolt, N. J., Meinitzer, A., Eder, M., Wascher, T. C., Pieber, T. R., Sourij, H.

    Published in Diabetic medicine (01-10-2012)
    “…Diabet. Med. 29, e365–e368 (2012) Aim  Endothelial dysfunction is defined by reduced bioavailability of nitric oxide and has been shown to be associated with…”
    Get full text
    Journal Article
  16. 16

    Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes by Schmoelzer, I, de Campo, A, Pressl, H, Stelzl, H, Dittrich, P, Oettl, K, Wascher, T C

    “…Premixed insulin analogues reduce postprandial hyperglycemia in patients with Type 2 diabetes in comparison to premixed regular insulin. Insulin also plays an…”
    Get more information
    Journal Article
  17. 17

    Contribution of the endothelium to transcapillary insulin transport in rat isolated perfused hearts by BRUNNER, F, WASCHER, T. C

    Published in Diabetes (New York, N.Y.) (01-07-1998)
    “…Contribution of the endothelium to transcapillary insulin transport in rat isolated perfused hearts. F Brunner and T C Wascher Department of Pharmacology and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction? by Graier, Wolfgang F., Posch, Karla, Fleischhacker, Eleonore, Wascher, Thomas C., Kostner, Gert M.

    Published in Diabetes research and clinical practice (01-09-1999)
    “…In diabetes mellitus, the risk for cardiovascular complications and development of atherosclerosis is increased compared with healthy individuals. Recently…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats by Wascher, T C, Wölkart, G, Russell, J C, Brunner, F

    Published in Diabetes (New York, N.Y.) (01-05-2000)
    “…Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats. T C Wascher , G Wölkart , J C Russell and F Brunner Department of Internal…”
    Get full text
    Journal Article